ScinoPharm Taiwan, Intangible Assets

ScinoPharm Taiwan, posts a intangible assets of $13M as of June 2026. That compares with $17M in the prior-year period — down 22.4% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, ScinoPharm Taiwan,'s intangible assets was $17M. The latest reading is $13M — a 22.4% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Intangible Assets is one piece of ScinoPharm Taiwan,'s financial statement story. At $13M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for 1789.TW's intangible assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; ScinoPharm Taiwan,'s other metric pages and overview cover the third.